about
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, ...
Read More
1.96
0.03
(1.55%)
3.1M
XNAS Volume
XNAS 05 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Vor Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..